Phasebio Pharmaceuticals Inc
PHASQ
Revenue
208.00k
▲91.00k▲77.78%
3 Months ChangeAssets
22.17M
▼-16.50M▼-42.67%
3 Months ChangeLiabilities
139.56M
▼-1.50M▼-1.06%
3 Months ChangeFree Cash Flow
-22.93M
▼-12.60M▼-121.94%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-05-16
Form 8-K
ID: 0001193125-24-140615
2024-03-12
Form 8-K
ID: 0001193125-24-065935
2023-11-29
Form 8-K
ID: 0001169245-23-000056
2023-10-03
Form 8-K
ID: 0001169245-23-000052
2023-09-27
Form 8-K
ID: 0001169245-23-000050
2023-08-25
Form 8-K
ID: 0001169245-23-000047
2023-06-30
Form 8-K
ID: 0001169245-23-000039
2023-05-30
Form 8-K
ID: 0001169245-23-000035
2023-05-10
Form 8-K
ID: 0001169245-23-000017
2023-03-24
Form 8-K
ID: 0001169245-23-000012